Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Developmental Brain Research
- Vol. 45 (1) , 95-101
- https://doi.org/10.1016/0165-3806(89)90011-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatumDevelopmental Brain Research, 1987
- Ontogeny of tolerance to haloperidol: Behavioral and biochemical measuresDevelopmental Brain Research, 1985
- Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390European Journal of Pharmacology, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to ratsNeuropharmacology, 1984
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- Increased mesolimbic 3H-spiroperidol binding in 4 week old offspring of nursing rat mothers treated with penfluridolEuropean Journal of Pharmacology, 1979
- Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol bindingEuropean Journal of Pharmacology, 1979
- Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidolBrain Research, 1977
- Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamineBritish Journal of Pharmacology, 1972